Literature DB >> 18618280

Anthropometric factors at age 20 years and risk of thyroid cancer.

Takeshi Suzuki1, Keitaro Matsuo, Yasuhisa Hasegawa, Akio Hiraki, Takakazu Kawase, Hideo Tanaka, Kazuo Tajima.   

Abstract

Effect of anthropometric factors at adolescence and the change since young age on thyroid cancer risk is unclear. Here, we conducted a case-control study to investigate the association between anthropometric factors at the time of diagnosis and age 20 years and risk of thyroid cancer. A total of 173 patients with thyroid cancer (papillary carcinoma, n = 167 and follicular carcinoma, n = 6) and 865 age- and sex-matched controls were included. Anthropometric factors were assessed using a validated self-administered questionnaire and categorized into three groups. Odd ratios (ORs) with 95% confidence intervals (CIs) were estimated using conditional logistic models adjusted for potential confounders. Results showed a positive association between current weights, weight at age 20 years and height, and thyroid cancer risk. Adjusted ORs in the top tertiles were 2.46 (95% CI, 1.54-3.94; trend p \ 0.001) for current weight, 2.69 (95% CI, 1.71-4.25; trend p \ 0.001) for weight at age 20 years and 2.44 (95% CI, 1.52-3.93; trend p \ 0.001) for height compared with the lowest tertile. A positive association with current body surface area (BSA), BSA at age 20 years, and current body mass index was also observed, with respective adjusted ORs in the top tertile of 1.96 (95% CI, 1.23-3.11; trend p = 0.007), 1.82 (95% CI, 1.15-2.88; trend p = 0.007) and 1.71 (95% CI, 1.06-2.78; trend p = 0.034). In contrast, no association with risk was seen for a change in anthropometric factors since age 20 years. These findings suggested that body size in early life as well as in adult is associated with an increased risk of thyroid cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18618280     DOI: 10.1007/s10552-008-9194-x

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  20 in total

1.  Anthropometric Factors and Thyroid Cancer Risk by Histological Subtype: Pooled Analysis of 22 Prospective Studies.

Authors:  Cari M Kitahara; Marjorie L McCullough; Silvia Franceschi; Sabina Rinaldi; Alicja Wolk; Gila Neta; Hans Olov Adami; Kristin Anderson; Gabriella Andreotti; Laura E Beane Freeman; Leslie Bernstein; Julie E Buring; Francoise Clavel-Chapelon; Lisa A De Roo; Yu-Tang Gao; J Michael Gaziano; Graham G Giles; Niclas Håkansson; Pamela L Horn-Ross; Vicki A Kirsh; Martha S Linet; Robert J MacInnis; Nicola Orsini; Yikyung Park; Alpa V Patel; Mark P Purdue; Elio Riboli; Kimberly Robien; Thomas Rohan; Dale P Sandler; Catherine Schairer; Arthur B Schneider; Howard D Sesso; Xiao-Ou Shu; Pramil N Singh; Piet A van den Brandt; Elizabeth Ward; Elisabete Weiderpass; Emily White; Yong-Bing Xiang; Anne Zeleniuch-Jacquotte; Wei Zheng; Patricia Hartge; Amy Berrington de González
Journal:  Thyroid       Date:  2016-02       Impact factor: 6.568

2.  Obesity Does Not Modify the Risk of Differentiated Thyroid Cancer in a Cytological Series of Thyroid Nodules.

Authors:  Mario Rotondi; Maria Grazia Castagna; Carlo Cappelli; Cristina Ciuoli; Francesca Coperchini; Francesco Chiofalo; Fabio Maino; Paola Palmitesta; Luca Chiovato; Furio Pacini
Journal:  Eur Thyroid J       Date:  2016-04-27

3.  Physical activity, diabetes, and thyroid cancer risk: a pooled analysis of five prospective studies.

Authors:  Cari M Kitahara; Elizabeth A Platz; Laura E Beane Freeman; Amanda Black; Ann W Hsing; Martha S Linet; Yikyung Park; Catherine Schairer; Amy Berrington de González
Journal:  Cancer Causes Control       Date:  2012-02-01       Impact factor: 2.506

4.  Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies.

Authors:  Cari M Kitahara; Elizabeth A Platz; Laura E Beane Freeman; Ann W Hsing; Martha S Linet; Yikyung Park; Catherine Schairer; Arthur Schatzkin; James M Shikany; Amy Berrington de González
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-01-25       Impact factor: 4.254

5.  Interaction between IGF-1 polymorphisms and overweight for the risk of pancreatic cancer in Japanese.

Authors:  Makoto Nakao; Satoyo Hosono; Hidemi Ito; Miki Watanabe; Nobumasa Mizuno; Yasushi Yatabe; Kenji Yamao; Ryuzo Ueda; Kazuo Tajima; Hideo Tanaka; Keitaro Matsuo
Journal:  Int J Mol Epidemiol Genet       Date:  2011-11-25

6.  Body fat distribution, weight change during adulthood, and thyroid cancer risk in the NIH-AARP Diet and Health Study.

Authors:  Cari M Kitahara; Elizabeth A Platz; Yikyung Park; Albert R Hollenbeck; Arthur Schatzkin; Amy Berrington de González
Journal:  Int J Cancer       Date:  2011-08-02       Impact factor: 7.396

7.  Obesity and the risk of papillary thyroid cancer: a pooled analysis of three case-control studies.

Authors:  Li Xu; Matthias Port; Stefano Landi; Federica Gemignani; Monica Cipollini; Rossella Elisei; Lilia Goudeva; Jörg Andreas Müller; Kai Nerlich; Giovanni Pellegrini; Christoph Reiners; Cristina Romei; Robert Schwab; Michael Abend; Erich M Sturgis
Journal:  Thyroid       Date:  2014-05-05       Impact factor: 6.568

8.  Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study.

Authors:  Cari L Meinhold; Elaine Ron; Sara J Schonfeld; Bruce H Alexander; D Michal Freedman; Martha S Linet; Amy Berrington de González
Journal:  Am J Epidemiol       Date:  2009-11-30       Impact factor: 4.897

9.  Thyroid cancer: current molecular perspectives.

Authors:  Francesca Giusti; Alberto Falchetti; Francesco Franceschelli; Francesca Marini; Annalisa Tanini; Maria Luisa Brandi
Journal:  J Oncol       Date:  2010-03-29       Impact factor: 4.375

10.  Recreational physical activity and risk of papillary thyroid cancer among women in the California Teachers Study.

Authors:  Stephanie Whisnant Cash; Huiyan Ma; Pamela L Horn-Ross; Peggy Reynolds; Alison J Canchola; Jane Sullivan-Halley; Shirley A A Beresford; Marian L Neuhouser; Thomas L Vaughan; Patrick J Heagerty; Leslie Bernstein
Journal:  Cancer Epidemiol       Date:  2012-10-30       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.